This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Knowing when to change your investment strategy is crucial. Discover key signs that indicate it's time to adapt.
24,241 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Germany plans sweeping changes to its pension system in 2026. This article breaks down what the reforms could mean fo...
Buffett’s moat mindset helps explain Netflix's AI edge. This article breaks down why the advantage may be temporary a...
A Singapore-based crypto miner reveals it has sold all mined Bitcoin to shore up liquidity for AI and high-performanc...
Ethereum confirms FOCIL will join the Hegota upgrade in 2026 while the Ethereum Foundation redirects a portion of its...
DeCaro Auctions appoints Mario Vargas as CEO, signaling a bold push into private-client advisory services and cross-b...
Match Group's chief executive opened a direct message channel to employees, turning feedback into action and reshapin...
ARMLS moves to an independent board with an advisory council to keep practitioner voices in governance. The transitio...
Worldcoin schedules a 43% reduction in daily WLD unlocks ahead of July 24, but nearly half of the supply has already ...
Tesla's robotaxi just launched in Miami, signaling a new era for the company’s autonomous ride-hailing push. This art...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
A WWII pivot from battleships to aircraft carriers and submarines reshaped global power and markets. Today’s investor...